GL1X · GenesisL1 explorer

MolNFT v1 · #52112 · protein

Crystal structure of G85R als mutant of human CU,ZN superoxide dismutase (cuznsod) at 1.36 a resolution

2VR8 · Superoxide dismutase [cu-zn]: “Crystal structure of G85R als mutant of human CU,ZN superoxide dismutase (cuznsod) at 1.36 a resolution”. X-ray diffraction, 5 ligands (ACE, ZN, CU), 2 pockets (best druggability 0.61). MolNFT v1…

PDB
2VR8
Type
protein
Length
306 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Superoxide dismutase [cu-zn]
EC
1.15.1.1
UniProt
P00441
Ligands
ACE, ZN, CU, SCN, SO4
Pockets
2 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, FSuperoxide dismutase [cu-zn] (EC 1.15.1.1)protein1536% helix, 39% strandP00441

Ligands and binding sites

  • ACE · Acetyl group · ligand · 2 copies · chains A, F
  • ZN · Zinc ion · metal · 6 copies · chains A, F
  • CU · Copper (II) ion · metal · 2 copies · chains A, F
  • SCN · Thiocyanate ion · ion · 4 copies · chains A, F
  • SO4 · Sulfate ion · ion · 2 copies · chains A, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12070.610.8232empty
2820.320.7416empty

Interfaces

1 interface between chains.

  • A–F · 692 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 disulfide, 2 modified (covalent ligand, disulfide, oxidation).

Compared structures

  • 2VR8 · Crystal Structure of G85R ALS mutant of Human Cu,Zn Superoxide Dismutase (CuZnSOD) at… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.